| scholarly article | Q13442814 |
| P50 | author | Zhongming Zhao | Q85219269 |
| Wael El-Rifai | Q90408769 | ||
| Mary Kay Washington | Q91454979 | ||
| Peilin Jia | Q96302804 | ||
| Rama Saad | Q114445878 | ||
| P2093 | author name string | Shoumin Zhu | |
| DunFa Peng | |||
| Zheng Chen | |||
| Zekuan Xu | |||
| P2860 | cites work | MicroRNAs: target recognition and regulatory functions | Q24609584 |
| Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers | Q24634248 | ||
| A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis | Q24649156 | ||
| MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma | Q24653676 | ||
| Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development | Q24674155 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma | Q28118779 | ||
| Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial | Q28222007 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| Molecular and biologic basis of upper gastrointestinal malignancy. Gastric carcinoma | Q30310204 | ||
| Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels | Q30502172 | ||
| MicroRNAs: tools for cancer diagnostics | Q33575602 | ||
| A microRNA expression signature for cervical cancer prognosis | Q33748347 | ||
| MicroRNA delivery by cationic lipoplexes for lung cancer therapy | Q34060310 | ||
| Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. | Q46972234 | ||
| Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. | Q53416418 | ||
| The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. | Q54365633 | ||
| MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. | Q54436240 | ||
| Polycomb Regulates NF-κB Signaling in Cancer through miRNA | Q57188641 | ||
| Gastric cancer | Q57758203 | ||
| Explaining gastric cancer survival differences among European countries | Q58218210 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer | Q34088885 | ||
| Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis | Q34089030 | ||
| MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta | Q34103001 | ||
| MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. | Q34120830 | ||
| OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. | Q34130311 | ||
| miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma | Q34166871 | ||
| Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. | Q34271727 | ||
| Role of innate immunity in Helicobacter pylori-induced gastric malignancy | Q34343194 | ||
| Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer | Q34377430 | ||
| Global cancer statistics in the year 2000. | Q34571897 | ||
| Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance | Q34992155 | ||
| MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer | Q35302023 | ||
| Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer | Q35541869 | ||
| Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality | Q35842975 | ||
| Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival | Q36076704 | ||
| Exposure to oral bisphosphonates and risk of esophageal cancer. | Q36441868 | ||
| Novel targets in gastric and esophageal cancer | Q36531079 | ||
| Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues | Q36575667 | ||
| MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma | Q37350288 | ||
| Helicobacter pylori: gastric cancer and beyond | Q37760037 | ||
| Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis | Q37776353 | ||
| MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer | Q37783459 | ||
| microRNAs in cancer: from bench to bedside | Q37804992 | ||
| Long noncoding RNAs in cardiac development and pathophysiology | Q38056111 | ||
| MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. | Q38332381 | ||
| MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). | Q38337024 | ||
| miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response | Q39439864 | ||
| MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer | Q39458980 | ||
| MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. | Q39467884 | ||
| miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo | Q39699946 | ||
| Recent patterns in gastric cancer: a global overview | Q39985871 | ||
| Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis | Q40612363 | ||
| Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus | Q42521348 | ||
| Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications | Q43964034 | ||
| Identification of novel microRNA targets based on microRNA signatures in bladder cancer | Q44199034 | ||
| Long-term survivors of gastric cancer: a California population-based study | Q46381551 | ||
| MicroRNA classifiers for predicting prognosis of squamous cell lung cancer | Q46661715 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| adenocarcinoma | Q356033 | ||
| gastric adenocarcinoma | Q18556047 | ||
| P304 | page(s) | 1985-1993 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma | |
| P478 | volume | 119 |
| Q38634473 | A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus |
| Q38511703 | A systematic study on dysregulated microRNAs in cervical cancer development |
| Q38679534 | Clinical value of integrated-signature miRNAs in esophageal cancer. |
| Q91636506 | Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer |
| Q38369160 | Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management |
| Q43108404 | Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer |
| Q47772895 | Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system. |
| Q47101112 | Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma |
| Q26780293 | Dysregulation of non-coding RNAs in gastric cancer |
| Q30659104 | Identification of a 5-gene signature for clinical and prognostic prediction in gastric cancer patients upon microarray data |
| Q38435781 | Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis |
| Q26780339 | May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers? |
| Q38728171 | MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA |
| Q28390889 | MicroRNA signature characterizes primary tumors that metastasize in an esophageal adenocarcinoma rat model |
| Q39281229 | MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell |
| Q55306139 | Optimizing miRNA-module diagnostic biomarkers of gastric carcinoma via integrated network analysis. |
| Q27012898 | Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications |
| Q26795757 | Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease |
| Q35218210 | SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells |
| Q33555190 | TAp63 suppress metastasis via miR-133b in colon cancer cells |
| Q26743549 | The Role of Mir-148a in Cancer |
| Q53589371 | The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer. |
| Q38261312 | The p53/microRNA connection in gastrointestinal cancer |
| Q38198572 | The role of miR-148a in gastric cancer |
| Q27024203 | The therapeutic value of targeting inflammation in gastrointestinal cancers |
| Q36214575 | Tumor profiling of gastric and esophageal carcinoma reveal different treatment options |
| Q41473012 | miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer |
| Q36734201 | miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer |
| Q38739532 | miR-564 is downregulated in gastric carcinoma and targets E2F3. |
Search more.